NHS Greater Glasgow and Clyde Recommends EMIS Software for 243 GPASS Practices

EMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software and related services to GPs, announces that NHS Greater Glasgow and Clyde has recommended EMIS software to replace the GPASS system used by 243 of its GP practices. The agreement is worth approximately £1m to EMIS in core annualised revenues.

NHS Scotland set out its eHealth Strategy 2008 - 2011 to replace the current GP System (GPASS) used by 683 practices across Scotland as part of a broader programme of support for improving eHealth in primary and community care. The market in Scotland has since opened up to competition with the objective to replace the existing system by March 2012.

Glasgow and Clyde is Scotland's largest health board with 269 GP practices, of which 243 currently use GPASS. Deployment of EMIS software will commence shortly at the Glasgow sites, with the full impact of the contract taking effect during 2011 onwards.

In January 2010, EMIS was selected by NHS National Services Scotland as one of only two companies to receive preferred bidder status and in the past few months the Company has undergone a robust tendering process with the health boards.

Prior to the formal notification of EMIS preferred bidder status, 51 GP practices within the Ayrshire and Arran Health Board had already chosen EMIS to replace its existing software. It is expected that other health boards will reach their decisions in the coming months.

Sean Riddell, Chief Executive of the Group, said: "This is excellent news for EMIS. As we outlined at the time of our IPO, Scotland represents a key growth market for the Company. As Scotland's largest health board, the Glasgow & Clyde contract makes up a significant proportion of that opportunity.

"We believe that EMIS' user-friendly format, advanced functionality and competitive pricing position us well for further growth in Scotland and we look forward to reporting additional successes in other parts of the country as the results of the tendering process are announced."

Anout EMIS Group
EMIS Group is the UK's leading supplier of software and related services to GP practices, with approximately 39 million patient records in the UK held on EMIS' software.

Established in 1987, EMIS' core activities include software licensing and support, hardware support and maintenance services, hardware sales, third party software sales and training services.

The Group's software includes all of the functionality specified in NHS accreditation standards for GPs, including holding the patient's cradle to grave electronic healthcare record, practice appointment booking systems and consultation and intelligent prescribing modules.

EMIS Web represents the next generation of clinical software systems and the Directors believe it has the potential to transform the delivery of healthcare by enabling GPs and other healthcare practitioners to connect with each other and securely share access to a patient's cradle to grave electronic health record.

For more information, visit www.emis-online.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...